drugset / Trial / NCT05676190

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

NCT05676190

Recruiting 80 enrolled ShiCang Yu
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This project plans to use CIK combined with chemotherapy, immunotherapy and targeted therapy to treat CRC patients, so as to explore the effectiveness of CIK treatment and the CRC subtypes more suitable for CIK treatment, thereby improving the survival rate and quality of life of CRC patients.

Timeline

Start
2023-01-09
Primary completion
2026-12-30
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CIK cells Cell therapy

Indications